Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pheochromocytoma × lanreotide × Endocrine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 13 Carcinoid Tumor 5 Serotonin Syndrome 2 Pituitary Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Acromegaly 2 Pheochromocytoma 1 Paraganglioma 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neuroendocrine Tumors in Lung 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Growth Hormone-Secreting Pituitary Adenoma 1 Gigantism 1 Gastrointestinal Neoplasms 1 Flushing 1 Diarrhea 1 Carcinoma, Hepatocellular 1 Carcinoid Heart Disease 1 Adenoma, Islet Cell 1

Interventions

3-Iodobenzylguanidine 12 lutetium Lu 177 dotatate 5 Temozolomide 5 gallium Ga 68 dotatate 4 Specimen Handling 4 Phenoxybenzamine 3 Magnetic Resonance Spectroscopy 3 Everolimus 3 3-fluorobenzylguanidine 3 pegfilgrastim 2 olaparib 2 belzutifan 2 anlotinib 2 Radiotherapy 2 Nivolumab 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Fluorodeoxyglucose F18 2 Filgrastim 2 Doxorubicin 2 Doxazosin 2 Dexmedetomidine 2 Capecitabine 2 Biopsy 2 Adrenalectomy 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 veliparib 1 vatalanib 1 tipifarnib 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03946527 2026-03-02

LAMPARA

Columbia University

Phase 2 Active not recruiting

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡